AU4201189A - Combination of quinolone antibiotics and steroids for topical ophthalmic use - Google Patents

Combination of quinolone antibiotics and steroids for topical ophthalmic use

Info

Publication number
AU4201189A
AU4201189A AU42011/89A AU4201189A AU4201189A AU 4201189 A AU4201189 A AU 4201189A AU 42011/89 A AU42011/89 A AU 42011/89A AU 4201189 A AU4201189 A AU 4201189A AU 4201189 A AU4201189 A AU 4201189A
Authority
AU
Australia
Prior art keywords
steroids
combination
topical ophthalmic
ophthalmic use
quinolone antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42011/89A
Other languages
English (en)
Inventor
Gerald D. Cagle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU4201189A publication Critical patent/AU4201189A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU42011/89A 1988-08-26 1989-08-24 Combination of quinolone antibiotics and steroids for topical ophthalmic use Abandoned AU4201189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23682888A 1988-08-26 1988-08-26
US236828 1988-08-26

Publications (1)

Publication Number Publication Date
AU4201189A true AU4201189A (en) 1990-03-23

Family

ID=22891134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42011/89A Abandoned AU4201189A (en) 1988-08-26 1989-08-24 Combination of quinolone antibiotics and steroids for topical ophthalmic use

Country Status (2)

Country Link
AU (1) AU4201189A (fr)
WO (1) WO1990001933A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065846B1 (es) * 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
CA2136803A1 (fr) * 1993-12-22 1995-06-23 Kazumi Ogata Derives de steroides
ES2088742B1 (es) 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
ES2105971B1 (es) * 1995-08-02 1998-07-01 S A L V A T Lab Sa Composicion antibiotica/antiinflamatoria de aplicacion otica.
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6440964B1 (en) * 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) * 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
AU6275999A (en) * 1998-09-30 2000-04-17 Alcon Laboratories, Inc. Antibiotic compositions for treatment of the eye, ear and nose
PL201130B1 (pl) 1999-09-24 2009-03-31 Alcon Inc Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa
DE10018783A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
DE10048510A1 (de) * 2000-09-29 2002-05-16 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
DE60137960D1 (de) * 2000-11-15 2009-04-23 Mohan A Chandavarkar Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva
EP1429780B1 (fr) 2001-09-21 2005-12-21 Alcon, Inc. Procede de traitement de l'infection de l'oreille moyenne
WO2004087043A2 (fr) * 2003-02-21 2004-10-14 Sun Pharmaceutical Industries Limited Composition ophtalmique stable
DK1864668T3 (da) 2006-06-01 2013-03-04 Novagali Pharma Sa Anvendelse af prodrug til okulær, intravitreal administration
WO2008085913A1 (fr) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Procédés pour traiter, prévenir, ou réduire le risque d'infections ophtalmiques, otiques, et nasales
EP2366408B1 (fr) 2010-03-01 2012-07-18 Laboratorios SALVAT, S.A. Solutions claires aqueuses d'acétonide de fluocinolone pour le traitement de l'inflammation otique
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150335704A1 (en) 2014-05-23 2015-11-26 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
US9393243B1 (en) 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
US11484515B2 (en) * 2017-12-12 2022-11-01 University of Pittsburgh—of the Commonwealth System of Higher Education Thermoresponsive hydrogel containing polymer microparticles for controlled drug delivery to the ear

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden

Also Published As

Publication number Publication date
WO1990001933A1 (fr) 1990-03-08

Similar Documents

Publication Publication Date Title
AU4201189A (en) Combination of quinolone antibiotics and steroids for topical ophthalmic use
AU567979B2 (en) Ophthalmic pharmaceutical compositions of norfloxacin and related antibiotics
AU637535B2 (en) Indane and quinoline derivatives
AU6417690A (en) Topical preparation for treatment of aphthous ulcers and other lesions
AU6392496A (en) The combination of topical nasal antihistamines and topical nasal steroids
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU3397989A (en) Alginate wound dressing of good integrity
AU5650890A (en) Indole derivatives and medicine
AU3831295A (en) 7-substituted 4-aza cholanic acid derivatives and their use
AU3192389A (en) Novel diazines and their method of preparation
AU5573390A (en) Fluorogenic compounds and their use
AU653064B2 (en) Hydrogel applicator and methods of making same
AU4977893A (en) Benzoxazole and bezothiazole derivatives
AU590640B2 (en) Dementia-improving and therapeutic agents
AU1846488A (en) Analgesic and anti-inflammatory thiourea derivatives
AU3760789A (en) Topical cosmetic and pharmaceutical preparation
AU3502789A (en) Composition and use
AU8427091A (en) Gamma-carboxylase and methods of use
AU7357887A (en) Dihydrorhodamines and halogenated derivatives thereof
AU4853690A (en) Cephalosporin derivatives and processes for their preparation
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
AU3744689A (en) Sunscreen composition and applicator system
AU3153289A (en) Cephalosporin derivatives and processes for their preparation
AU2887889A (en) Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
AU4548289A (en) Penem derivatives and processes for their preparation